ERBB4 Antibody

1. Studied association of two erb-b2 receptor tyrosine kinase 4 (ERBB4) polymorphisms with genetic predisposition of schizophrenia in a Jordanian Arab population. PMID: 28425244
2. ERBB4 rs1351592 confers risk for polycystic ovary syndrome in Han Chinese. PMID: 28195137
3. Results found that ERBB4 was highly expressed in gastric cancer cell (GC) lines and tumors and closely related to the poor prognosis of GC patients. Other data indicated that ERBB4 promoted cell proliferation via PI3K/Akt signaling pathway. PMID: 29620274
4. Study found that the protein levels of NRG1 and ErbB4 were significantly increased in the temporal cortex of patients with symptomatic epilepsy. Also, NRG1-ErbB4 signaling suppresses GluN2B phosphorylation by Src inhibition. GluN2B is closely related to synaptic activity and its regulation by the NRG1-ErbB4-Src signaling axis highlights the importance of NRG1-ErbB4 signaling in symptomatic epilepsy pathology. PMID: 28273943
5. present study shows that HER4 and/or NDRG1 might play a critical role for the cell survival and chemo-resistance of Osteosarcoma (OS), and could be used as potential therapeutic targets in OS. PMID: 29524631
6. This study support the involvement of Neuregulin signaling pathway in smoking behavior but not in alcohol use and abuse, and disclose functional potential for 56 of the 66 associated single-nucleotide polymorphism and underlining the involvement of ERBB4 in SI, ND and NW. PMID: 28892072
7. These finding suggests that miR-302b inhibits key transcription factors and cytokines by targeting ERBB4, IRF2 and CXCR4, implicating its role in the inhibition of CRI in EC. PMID: 28467773
8. we have exploited the hidden information inside ErbB4 kinase receptor both at sequence and structural level. PSI-BLAST algorithm is used to search similar sequences against ErbB4 kinase sequence. Top 15 sequences with high identity were selected for finding conserved and variable regions among sequences using multiple sequence alignment PMID: 28670936
9. Receptor protein-tyrosine kinase ErbB-4 (ERBB4) is expressed in the basal layer of human epidermis and cultured keratinocytes as well as in murine epidermis. PMID: 29410073
10. our study demonstrated and highlighted the strong prognostic value of HER4 in breast cancer carcinoma. The detection of the strong association of cytoplasmic HER4 with RFS might serve as an effective tool for investigating the multifunctionality of HER4 in predicting prognosis and its possible contribution to providing optimal treatment to patients with cancer. PMID: 27736797
11. In silico analysis suggested that rs1972820 located in the 3'UTR of ERBB4 gene affects the binding affinity of miR-3144-3p a potential oncomiRNA. Statistical analysis showed a significant association between SNP rs1972820 G allele and reduced breast cancer risk, odds ratio = 0.443 (95% CI: 0.196-0.998). PMID: 28508829
12. conclude from these results that this loss in Intron 1 of the ERBB4 gene is neither a de novo driver mutation nor a predisposing factor to GBM, despite the indications from CCLE PMID: 29342193
13. findings indicate that a SUMOylation-mediated mechanism regulates nuclear localization and function of the ICD of ErbB4 receptor tyrosine kinase PMID: 28974580
14. Convergence between EGFR/ErbB4 and canonical/noncanonical Wnt signaling determines cardiogenic fate in human pluripotent stem cells. PMID: 27324647
15. ERBB4 gene polymorphism is associated with the risk of congestive heart failure and prognosis in Chinese people. PMID: 26844763
16. High ERBB4 expression is associated with Merkel cell carcinoma PMID: 28359267
17. High ERBB4 expression is associated with colon cancer metastasis. PMID: 28629469
18. ERBB4 mutation is associated with Metaplastic Breast Cancer. PMID: 27568101
19. Results show higher expression levels of ErbB4 and KITENIN in stage IV colorectal cancer tissues resulting in elevated phosphorylated level of ERBB2. PMID: 27648936
20. review and meta-analysis, does not play essential role in clinicopathology and prognosis of gastric cancer PMID: 27536774
21. We directly link TDP-43 loss of function toxicity to two genes with rare amyotrophic lateral sclerosis and frontotemporal lobar degeneration-causing mutations, CHMP2B and ErbB4 PMID: 27621269
22. Parallel microarray profiling identifies Erbb4 as a marker of cyst growth in autosomal dominant polycystic kidney disease and as a prognostic marker for disease progression. PMID: 28077374
23. the HER4 G1109C mutation is an activating oncogenic mutation with a transformational ability and that afatinib was effective against an HER4 G1109C-mutated HNSCC cell line by inhibiting the HER4 signal, both in vitro and in vivo. PMID: 27207775
24. identified a novel Her4-induced posttranslational modification on MDMX PMID: 27777309
25. In this study, we aimed to investigate the association of ERBB4 rs707284 with the risk of Schizophrenia in an Iranian population. There was no association between the risk of Schizophrenia and rs707284. PMID: 28384043
26. Meta-analysis identified a statistically significant association between ErbB4 SNP rs707284 and susceptibility to schizophrenia among Asian and Caucasian populations under allelic model and marginal associations under recessive and homozygous models. In addition, in Asian subgroup analysis, rs707284 was marginally associated with schizophrenia under the recessive model. PMID: 28225484
27. Our results indicated that SNP rs11895168 C allele located in ErbB4 3'UTR was significantly associated with elevated breast cancer risk. PMID: 27262100
28. Advanced bioinformatic analysis softwares were used to analyze the regulatory mechanism after ErbB4 gene mutation in terms of amino acid sequence, primary, secondary, and tertiary structure of the protein and upstream-downstream receptor/ligands. Mutation of the 19th and 113th amino acids at the carboxyl terminus of ErbB4 protein did not affect its biological nature, but its secondary structure changed PMID: 27323039
29. High ERBB4 Expression is associated with Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy. PMID: 28178720
30. interaction with rs1836724 C variant within ErbB4 may be associated with higher expression of ESR1 (ERpositive phenotype). PMID: 27035115
31. haplotypes CAAAI and TAAAD (rs12052398, rs13393577, rs13424871, rs16847082 and rs6147150I) of the ERBB4 polymorphisms are associated with a significantly lower risk of prostate cancer. PMID: 27609473
32. Results from the expression profile of ERBB4 suggest that it might serve as a prognostic marker in patients with triple negative breast cancer. PMID: 26907936
33. Genetic variants in ERBB4 is associated with chronic hepatitis B virus infection. PMID: 26701850
34. The connections of EGFR and ERBB4 signaling with SREBP-2-regulated cholesterol metabolism are likely to be important in ERBB-regulated developmental processes and may contribute to metabolic remodeling in ERBB-driven cancers. PMID: 26535009
35. nuclear HER4 seem to be co-located with estrogen receptors, however, we did not find support for overall HER4 expression in independently predicting response of tamoxifen treatment in breast cancer PMID: 26238412
36. the presence of activating driver mutations of ERBB4 in non-small cell lung cancer PMID: 26050618
37. A combination of miRNAs induced via endothelial coculture improved embryonic-stem-cell-derived cardiomyocytes maturity, in part through suppression of ErbB4 signaling. PMID: 26365191
38. Identification of a new subclass of ALK-negative Anaplastic large-cell lymphoma characterized by aberrant expression of ERBB4-truncated transcripts carrying intronic 5' untranslated regions. PMID: 26463425
39. In this study, we developed an anti-ErbB4 mAb (clone P6-1) that suppresses NRG-dependent activation of ErbB4 and examined its effect on breast cancer cell proliferation in the extracellular matrix. PMID: 26780728
40. Dysregulated ErbB4splicing in schizophreniamay contribute to lower activity of parvalbumin interneurons and an activity-dependent down-regulation of parvalbumin expression. PMID: 26337038
41. NRG4 and its receptor ErbB4 are present in human breast milk and developing human intestine, respectively. Thus, NRG4-ErbB4 signaling may be a novel pathway for therapeutic intervention or prevention in NEC. PMID: 25216938
42. s investigated the effects of ERBB4 variants and family history of SCZ and/or BPD (FH) on cortical measures and cognitive performances. PMID: 25744101
43. There are isoform-specific roles of ERBB4 during puberty and early pregnancy. CYT-1 ERBB4a has oncogenic properties. PMID: 25516216
44. Elevated ERBB4 expression is associated with drug resistance in colorectal cancer. PMID: 24893630
45. ERBB4 is over-expressed in human colon cancer and enhances cellular transformation. PMID: 25916654
46. amplification of ERBB4, C-MET and CD44 was significantly associated with certain clinicopathological characteristics, particularly tumor differentiation and cancer-related death and poor survival. PMID: 22606006
47. identifying neuregulin 1 and its cognate receptor ERBB4 [epidermal growth factor receptor (EGFR) family member v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4] as a major receptor complex that activates YAP activity PMID: 25492964
48. These observations connect the unusual nuclear function of a growth factor receptor with a mechanosensory pathway and suggest that NRG1-ERBB4-YAP signaling contributes to the aggressive behavior of tumor cells. PMID: 25492965
49. A small cluster located in the 5' end of the ERBB4 gene showed a nominal association mainly with negative, general and total dimensions of the Positive and Negative Syndrome Scale. PMID: 25142529
50. Our data suggested that individuals in Chinese population with the ErbB4 12-bp deletion allele may be at higher risk for CRC, rs6147150 would potentially be a promising novel biomarker for Colorectal cancer susceptibility PMID: 25335735

显示更多

收起更多

HGNC: 3432

OMIM: 600543

KEGG: hsa:2066

STRING: 9606.ENSP00000342235

UniGene: Hs.390729